SIM
DRNA

SSI Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

SSI Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,110
Closed -$192K – 406
2014
Q3 		$192K Buy
+15,110
New +$228K 0.02% 364

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSI Investment Management's DRNA Position: Q4 2014 in Review

SSI Investment Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2014, closing a stake of 15,110 shares — an estimated $192K sold.

SSI Investment Management first reported a position in DRNA in Q3 2014 and held it in 1 quarter. The position peaked at $192K in Q3 2014. 47 funds tracked by Wall St. Rank hold DRNA as of Q4 2014.

  • SSI Investment Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • SSI Investment Management sold 15,110 Dicerna Pharmaceuticals, Inc. shares in Q4 2014, an estimated $192K.
  • SSI Investment Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • SSI Investment Management's Dicerna Pharmaceuticals, Inc. position peaked at $192K in Q3 2014.
  • 47 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2014.

Based on SSI Investment Management's 13F filing for Q4 2014, filed 11 Feb 2015.